IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
DICE News
Archived Headlines
CAVA soars 99% in one of the best first days for a larger IPO in the past two years
Restaurant chain CAVA Group (CAVA) soared 99% in its debut on Thursday, delivering one of the best first-day performances for a $100+ million IPO in the past two years. ...read more
US IPO Weekly Recap: The Fall IPO market is in full swing with an 11 IPO week
The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. Tech consultancy Thoughtworks (TWKS) raised $774 million at a $7.0 billion market cap. This agile software developer...read more
Immunology biotech DICE Therapeutics prices upsized IPO at $17 high end
DICE Therapeutics, a Phase 1-ready biotech developing oral small molecule therapies for immunologic diseases, raised $204 million by offering 12 million shares at $17, the high end of the range of $15 to $17. The company offered 2 million more shares than anticipated. DICE is leveraging its proprietary technology platform, which it refers to as DELSCAPE, to build a pipeline...read more
US IPO Week Ahead: The Fall IPO market kicks off with an 11 IPO week
Updated Monday, 9/13. After a wave of launches in the short holiday week, 11 IPOs are scheduled to raise over $3 billion in the week ahead. Tech consultancy Thoughtworks (TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more...read more